Member access

4-Traders Homepage  >  Shares  >  Deutsche Boerse AG  >  Zeltia SA    ZEL   ES0184940817

ZELTIA SA (ZEL)

0
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Zeltia SA
Operates as a biopharmaceutical company

Zeltia SA is a biopharmaceutical company, which specialized in the development of marine-based drugs for use in oncology.

The company operates through two main business segments: Biopharmaceuticals and Consumer Chemicals.

The Biopharmaceuticals business segment engages in the research, development and marketing of antitumor drugs through Pharma Mar SAU, the development and marketing of diagnosis kits through Genómica SAU and the development of therapies based on reducing or silencing gene expression through Sylentis SA. The Consumer Chemicals business segment produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products through various subsidiaries, which include Zelnova SA, Xylazel SA and Copyr SpA. Zeltia was founded on August 3, 1939 and is headquartered in Madrid, Spain.
Surperformance© rating of Zeltia SA
Overall rating In sector In country
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
PER
Potential
Yield - - -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
More Ratings
Sector
Basic Materials
Chemicals
 Chemicals
  Chemicals - Diversified
Advertisement
Sector Chemicals - Diversified
Trading RatingInvestor Rating
SAUDI BASIC INDUS..
E I DU PONT DE NE..
THE DOW CHEMICAL ..
INDUSTRIES QATAR ..
AKZO NOBEL
Sector Chemicals - Diversified
Company contact information
Zeltia SA
Plaza Descubridor Diego de Ordás, 3
Planta 5
Madrid 28003

Phone : +34.91.444.45.00
Fax : +34.91.593.29.94
Web : www.zeltia.es
© 2014 Factset   
Dynamic quotes  
ON
| OFF